Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

Market Cap	4.99B -40.4%
Revenue (ttm)	2.89B -5.3%
Net Income	306.36M -34.7%
EPS	0.63 -31.5%
Shares Out	494.11M
PE Ratio	16.07
Forward PE	9.97
Dividend	0.40 (3.96%)
Ex-Dividend Date	May 28, 2026

Volume	2,934,570
Open	10.58
Previous Close	10.27
Day's Range	10.09 - 10.58
52-Week Range	9.26 - 17.37
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:300705

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches, ketoprofen gel patches, pantopril sodium enteric-coated tablets, dapagliflozin tablets, and rosuvastatin calcium. It also provides digestive system an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,298
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300705

Financial Performance

In 2025, SHE:300705's revenue was 3.11 billion, an increase of 6.15% compared to the previous year's 2.93 billion. Earnings were 472.82 million, a decrease of -7.72%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error